Section snippets

Authors' contributions:

All authors were responsible for the study concept, data acquisition and analysis, the integrity of the data and the accuracy of the data analysis, the drafting, and the critical revision of the manuscript for important intellectual content, and approved the final version of the article. Terry Yip is the submission’s guarantor of the article.

Financial support:

None

Declaration of Competing Interest:

Jimmy Lai has served as a speaker for Gilead Sciences and an advisory board committee for Gilead Sciences and Boehringer Ingelheim.Terry Yip has served as an advisory committee member and a speaker for Gilead Sciences.Mary Wang declares that she has no competing interests.We extend our sincere gratitude to Ge et al. [1] for their valuable insights on our territory-wide cohort study, which involved patients identified from the Clinical Data Analysis and Reporting System (CDARS) of the Hospital

中文翻译：

---

回复： “替诺福韦和恩替卡韦的骨折风险洞察：来自药物警戒数据的证据”

 部分片段

 作者贡献：

所有作者负责研究概念、数据采集和分析、数据的完整性和数据分析的准确性、起草和对重要知识内容的手稿进行关键修改，并批准了文章的最终版本。Terry Yip 是该文章的提交担保人。

 资金支持：

 没有

利益争夺声明：

Jimmy Lai 曾担任 Gilead Sciences 的发言人以及 Gilead Sciences 和 Boehringer Ingelheim 的顾问委员会。Terry Yip 曾担任 Gilead Sciences 的顾问委员会成员和发言人。Mary Wang 声明她没有竞争利益。我们衷心感谢 Ge 等人 [1] 对我们的全港队列研究的宝贵见解，该研究涉及从医院临床数据分析和报告系统 （CDARS） 确定的患者